These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 18327889

  • 1. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G.
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [Abstract] [Full Text] [Related]

  • 2. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
    Yoon SJ, Pae CU, Kim DJ, Namkoong K, Lee E, Oh DY, Lee YS, Shin DH, Jeong YC, Kim JH, Choi SB, Hwang IB, Shin YC, Cho SN, Lee HK, Lee CT.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1196-201. PubMed ID: 16624467
    [Abstract] [Full Text] [Related]

  • 3. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar 30; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Mar 30; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 5. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar 30; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 6. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug 30; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 7. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
    Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L.
    Hum Psychopharmacol; 2005 Aug 30; 20(6):435-40. PubMed ID: 16106478
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May 30; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 9. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M.
    J Clin Pharm Ther; 2005 Apr 30; 30(2):133-8. PubMed ID: 15811165
    [Abstract] [Full Text] [Related]

  • 10. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ, Kasper S, Müller H, Kissling W, Fuger J, Ruhrmann S.
    Pharmacopsychiatry; 1995 Nov 30; 28(6):249-52. PubMed ID: 8773291
    [Abstract] [Full Text] [Related]

  • 11. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Nov 30; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 12. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA, Moleman P, Mulder PG, van den Broek WW.
    Pharmacopsychiatry; 1999 May 30; 32(3):87-92. PubMed ID: 10463374
    [Abstract] [Full Text] [Related]

  • 13. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
    Høyberg OJ, Maragakis B, Mullin J, Norum D, Stordall E, Ekdahl P, Ose E, Moksnes KM, Sennef C.
    Acta Psychiatr Scand; 1996 Mar 30; 93(3):184-90. PubMed ID: 8739664
    [Abstract] [Full Text] [Related]

  • 14. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD, Kundhur D, Solomons K, Yatham LN, Lam RW.
    J Psychiatry Neurosci; 2003 Jan 30; 28(1):55-9. PubMed ID: 12587851
    [Abstract] [Full Text] [Related]

  • 15. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Jan 30; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 16. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R, Zaninelli R, Contu A, Oberhoff C, Gutschow K, Schindler AE, Staab HJ.
    Zentralbl Gynakol; 2000 Jan 30; 122(4):195-202. PubMed ID: 10795116
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
    Stahl S, Zivkov M, Reimitz PE, Panagides J, Hoff W.
    Acta Psychiatr Scand Suppl; 1997 Jan 30; 391():22-30. PubMed ID: 9265948
    [Abstract] [Full Text] [Related]

  • 18. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.
    Biol Psychiatry; 2006 Jun 01; 59(11):1071-7. PubMed ID: 16497273
    [Abstract] [Full Text] [Related]

  • 19. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 01; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 20. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
    Montgomery SA, Reimitz PE, Zivkov M.
    Int Clin Psychopharmacol; 1998 Mar 01; 13(2):63-73. PubMed ID: 9669186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.